SHINPOONG PHARMACEUTICAL CO.,LTD |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12,570 KRW | -3.83% |
|
-5.13% | -7.03% |
| 2023 | South Korean Shares Continue Losing Streak Amid High Interest Rate Woes | MT |
| 2023 | Financial Regulator Probes Shinpoong Pharmaceutical Employees for Trading Using Undisclosed Information | MT |
| Sales 2022 | 209B 152M | Sales 2023 | 200B 146M | Capitalization | 707B 515M |
|---|---|---|---|---|---|
| Net income 2022 | -35.38B -25.75M | Net income 2023 | -57.32B -41.73M | EV / Sales 2022 | 5.12 x |
| Net cash position 2022 | 53.99B 39.3M | Net cash position 2023 | 14.43B 10.5M | EV / Sales 2023 | 3.46 x |
| P/E ratio 2022 |
-31.9
x | P/E ratio 2023 |
-12.1
x | Employees | 828 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 58.9% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | -3.83% | ||
| 1 week | -5.13% | ||
| Current month | -18.96% | ||
| 1 month | +7.07% | ||
| 3 months | +2.03% | ||
| 6 months | -7.64% | ||
| Current year | -7.03% |
1 week
12 400.00
13 500.00
1 month
12 170.0019 850.00
Current year
11 180.0019 850.00
1 year
9 560.0022 800.00
3 years
9 560.00111 000.00
5 years
4 940.00214 000.00
10 years
3 653.82214 000.00
| Managers | Title | Age | Since |
|---|---|---|---|
Je-Man Yoo
CEO | Chief Executive Officer | 67 | 14-03-20 |
Jin-Gyu Park
DFI | Director of Finance/CFO | 59 | - |
Chung Joo
CTO | Chief Tech/Sci/R&D Officer | 51 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Hyun-Jae Cho
BRD | Director/Board Member | 53 | 13-03-28 |
Je-Man Yoo
CEO | Chief Executive Officer | 67 | 14-03-20 |
Chan-Ho Lee
BRD | Director/Board Member | 52 | 20-03-26 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.01% | 4 M€ | -4.41% | - | |
| 0.00% | 117 M€ | -1.55% | - | |
| 0.00% | 7 M€ | -0.18% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-18 | 12,570 | -3.83% | 233 577 |
| 24-04-18 | 13,070 | +2.43% | 116,478 |
| 24-04-17 | 12,760 | -1.77% | 155,825 |
| 24-04-16 | 12,990 | -2.48% | 175,294 |
| 24-04-15 | 13,320 | -2.77% | 187,763 |
End-of-day quote Korea S.E., April 18, 2024
More quotes
Shin Pooong Pharm., Co. Ltd is a Korea-based company mainly engaged in the manufacture of pharmaceuticals. The Company's product portfolio consists of antibiotics, cardiovascular drugs, anti-cancer drugs, psychoneurotic drugs, antirheumatic drugs, antidiabetics, antifungal agents, antihistamines, antiviral agents, benign prostatic hyperplasia (BPH) drugs and trichogens. The Company also provides active pharmaceutical ingredients (APIs) synthesized by the Company, including non-steroidal anti-inflammatory drugs (NSAIDs), cardiovascular drugs, anti-ulcer drugs, respiratory drugs, antispasmodics drugs and others. The Company distributes its products within domestic market and to overseas markets.
Sector
Pharmaceuticals
Calendar
2024-05-12
- Q1 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -7.03% | 504M | |
| +20.91% | 43.54B | |
| +16.96% | 21.74B | |
| +9.05% | 13.53B | |
| +7.98% | 13.02B | |
| +33.80% | 11.28B | |
| -11.05% | 6.99B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +6.64% | 5.09B |
- Stock Market
- Equities
- A019170 Stock
